CompletedPhase 1/2

World Health Organization (WHO) , COVID19 Case Series of Post Covid 19 Rhino Orbito Cerebral Mucormycosis in Egypt

Egypt35 participantsStarted 2021-05-23

Plain-language summary

Objectives: identify and recognize clinical Characteristics, Pathophysiology, and management of a group of patients with rhino Rhino-Orbito-Cerebral Mucormycosis infection associated with Covid 19 viral infection

Who can participate

Age range22 Years – 77 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * all patients with mucormycosis post covid 19 Exclusion Criteria: * The patient not suffered from covid 19

What they're measuring

35 patients suffering from mucormycosis infection post covid 19

Timeframe: 2 years

25 patients were cured with comorbidity and 10 pateints died

Timeframe: 2 years

pain

Timeframe: two years

Trial details

NCT IDNCT06267326

SponsorNasser Institute For Research and Treatment

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2022-06-12

View on ClinicalTrials.gov More Mucormycosis; Rhinocerebral (Etiology) trials